RDNT Competitors & Alternatives
Compare RadNet Inc with similar stocks in the same industry
Diagnostics & Research
RDNT
Main Stock$73.45
Tradestie Score
45
Market Cap
$6.00B
Revenue Growth
0.3%
Analyst Upside
+28.8%
Top Competitors
38 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CRL
Charles River Laboratories International, Inc.
|
$272.84
|
$8.39B | - | 41 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$159.43
|
$7.81B | - | 60 | Compare |
|
BLLN
BLLN
|
$99.73
|
$4.67B | 137.6 | 55 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$18.38
|
$4.60B | 32.6 | 47 | Compare |
|
LNTH
Lantheus Holdings, Inc
|
$100.60
|
$3.51B | 24.0 | 46 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$83.66
|
$3.26B | - | 45 | Compare |
|
VCYT
Veracyte, Inc.
|
$42.86
|
$2.85B | 30.3 | 61 | Compare |
|
SGRY
Surgery Partners, Inc. Common Stock
|
$13.95
|
$2.72B | - | 55 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$77.41
|
$2.24B | - | 44 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$24.09
|
$2.22B | - | 56 | Compare |
More RDNT Analysis
Data updated: Sep 10, 2026 | Industry: Diagnostics & Research (SIC 8071)
38 stocks in this industry